NST — Nestmedic SA Income Statement
0.000.00%
- PLN17.30m
- PLN18.09m
- PLN1.15m
Annual income statement for Nestmedic SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | PAS | PAS | PAS | PAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.371 | 0.655 | 1.87 | 1.55 | 1.15 |
Cost of Revenue | |||||
Gross Profit | 0.24 | 0.096 | 0.81 | 0.952 | 0.838 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.24 | 4.2 | 6.52 | 7.84 | 6.11 |
Operating Profit | -3.87 | -3.55 | -4.65 | -6.29 | -4.96 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.24 | -3.91 | -4.95 | -6.77 | -5.27 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.24 | -3.91 | -4.95 | -6.77 | -5.27 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.24 | -3.91 | -4.95 | -6.77 | -5.27 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.24 | -3.91 | -4.95 | -6.77 | -5.27 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.588 | -0.419 | -0.263 | -0.275 | -0.193 |
Dividends per Share |